49 related articles for article (PubMed ID: 15060691)
1. Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.
Liao YR; Yen CP; Lin CC; Fu LS; Chiu CC; Chi CS
J Microbiol Immunol Infect; 2004 Feb; 37(1):67-70. PubMed ID: 15060691
[TBL] [Abstract][Full Text] [Related]
2. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
Yang SS; Fu LS; Chang CS; Yeh HZ; Chen GH; Kao JH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1789-93. PubMed ID: 17074015
[TBL] [Abstract][Full Text] [Related]
3. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
[TBL] [Abstract][Full Text] [Related]
4. Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin.
Lee S; Macquillan GC; Keane NM; Flexman J; Jeffrey GP; French MA; Brochier J; Price P
Immunol Cell Biol; 2002 Aug; 80(4):391-7. PubMed ID: 12121229
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
6. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
7. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
8. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
[TBL] [Abstract][Full Text] [Related]
9. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
[TBL] [Abstract][Full Text] [Related]
10. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
Gerner P; Hilbich J; Wenzl TG; Behrens R; Walther F; Kliemann G; Enninger A; Wirth S
J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders.
Hasan F; Asker H; al Shamali M; al Kalaoui M; al Nakib B
Hepatogastroenterology; 2000; 47(36):1642-4. PubMed ID: 11149023
[TBL] [Abstract][Full Text] [Related]
12. [Sustained virological response in children with chronic hepatitis C treated with interferon alpha and ribavirin].
Woźniakowska-Gesicka T; Kupś J; Wiśniewska-Ligier M
Przegl Lek; 2005; 62(12):1405-8. PubMed ID: 16786760
[TBL] [Abstract][Full Text] [Related]
13. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
14. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
15. Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy.
Radu C; Dejica D; Grigorescu M; Zaharie T; Neculoiu D
Rom J Gastroenterol; 2003 Jun; 12(2):91-5. PubMed ID: 12853993
[TBL] [Abstract][Full Text] [Related]
16. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
17. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
18. Therapy of hepatitis C: alpha interferon and ribavirin.
Reichard O; Schvarcz R; Weiland O
Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
[TBL] [Abstract][Full Text] [Related]
19. Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan.
Lai MY
Intervirology; 2006; 49(1-2):91-5. PubMed ID: 16166795
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis C.
Di Cesare E; Spadaro A; Ajello A; Ferraù O; Alessi N; Luigiano C; Melluso R; Freni MA
Clin Chem Lab Med; 2005; 43(8):823-6. PubMed ID: 16201891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
